Presented at the 5th International Symposium on Mushroom Nutrition, University of Westminster, June 14th, 2002.
This abstract outlines the impact of using 4.5 grams per day of Coriolus versicolor supplementation in a breast cancer patient undergoing chemotherapy. The case study outlines the significant impact of Coriolus supplementation on immune parameters and on the quality of life for the patient.
To contact Dra. Ana Ferro / Paula Boaventura
Clinica de Saúde Integral
Rua Constitução, 1959-loja A 4250 / 170 Porto, Portugal
Tel:351-22-832-80-47 / Fax:351-22-832-80-49
Clinical Articles
The following section outlines the clinical papers, posters and proposals that refer to the clinical use of MRL mushroom nutrition products. This information is for healthcare practitioners only and should not be provided to members of the general public.
Download PDF
Clinical articles
-
Hericium Erinaceus Prevents DEHP-Induced Mitochondrial Dysfunction and Apoptosis in PC12 Cells
Ines Amara (1)(2), Maria Scuto (2), Agata Zappalà (2), Maria Laura Ontario (2), Antonio Petralia (3), Alwa Abid -Essefi (1), Luigi Maiolino (3), Anna Signorile (4), Angela Trovato Salinaro (2) and Vittorio Calabrese (2). -
Effect of combined therapy polyhexamethylene biguanide and Coriolus-MRL on human papilloma virus (HPV) cervical and vulvar-related lesions
D. Gincheva(1), V. Gincheva(2), E. Konova(1)
-
Nutritional Mushroom Treatment in Meniere’s Disease with Coriolus versicolor: A Rationale for Therapeutic Intervention in Neuroinflammation and Antineurodegeneration
Maria Scuto (1),y , Paola Di Mauro (2),y, Maria Laura Ontario (1), Chiara Amato (2), Sergio Moda_eri (1), Domenico Ciavardelli (3,4), Angela Trovato Salinaro (1), Luigi Maiolino (2),* and Vittorio Calabrese (2) -
Evaluation of the prebiotic potential of Coriolus versicolor-Effect on the human gut microbiota.
C.M. Costa, S. Silva, L. Pimentel and M.M. Pintado